Carlson

Revision as of 00:50, 16 June 2018 by Gordoben (talk | contribs) (Imported from Wikispaces)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

The topical nasal decongestant, oxymetazoline, did not reduce the rate of middle-ear barotrauma in patients having hyperbaric oxygen therapy.

Clinical Bottom Line: 1. No evidence that topical decongestants reduce middle ear barotrauma.

    • Appraised by: Mike Bennett, Dept of Diving and Hyperbaric Medicine, Prince of Wales Hospital

Sydney; Thursday, 04 February, 1999

    • Clinical Scenario: A patient presents for hyperbaric oxygen therapy. We wondered if topical nasal decongestants would decrease the incidence of aural barotrauma.
    • Three-part Question: In patients undergoing hyperbaric oxygen therapy, does the pre-hyperbaric use of topical nasal decongestant compared to no specific pre-treatment, result in less middle ear barotrauma?
    • Search Terms: ear, middle, barotrauma, nasal decongestants
    • The Study:

Double-blinded concealed randomised controlled trial with intention-to-treat. Adults requiring hyperbaric therapy for acute carbon monoxide poisoning and able to make informed consent. Control group (N = 30; 30 analysed): Two sprays of sterile water into each nostril at least 15 minutes prior to hyperbaric exposure at 2.4 ATA. Experimental group (N = 30; 30 analysed): Two sprays of oxymetazoline hydrochloride into each nostril at least 15 minutes prior to hyperbaric exposure at 2.4 ATA.

    • The Evidence:
Outcome Water group rate Oxymet group rate Relative risk increase Absolute risk increase NNH
Teed score > zero after treatment 0.4 0.467 17% 0.067 15
95% CI: -46% to 79% -0.183to 0.317 NNH 3 to INF NNT = 5to INF
Ear pain on compression 0.2 0.300 50% 0.100 10
95% CI: -59% to 100% -0.118 to 0.318 NNH 3 to INF NNT = 8 to INF
Asymptomatic compression 0.333 0.367 10% -0.034 29
95% CI: -62% to 83% -0.207 to 0.275 NNH 4 to INF NNT = 5 to INF
    • Comments:

1. Well-designed study with 80% power to detect 50% reduction in the incidence of barotrauma. 2. All CO poisoned patients, probably treated in a monoplace chamber. 3. Most patients experienced some discomfort in the ears. 4. Compression rate not specified.

    • Expiry date: June 2020
    • References: 1. Carlson S, Jones J, Brown M, Hess C. Prevention of hyperbaric-associated middle ear barotrauma. Annals of Emergency Medicine 1992; 21:1468-1471.
Sumhorsa.gif


BACK